Navigation Links
BioLineRx Reports Third Quarter 2013 Financial Results
Date:11/13/2013

ities and Exchange Commission on March 12, 2013. In addition, any forward-looking statements represent BioLineRx's views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. BioLineRx does not assume any obligation to update any forward-looking statements unless required by law.

Contact:Garth Russell / Todd Fromer
KCSA Strategic Communications
1 212-896-1250 / 1 212-896-1215
grussell@kcsa.com / tfromer@kcsa.com

Tsipi Haitovsky
Public Relations
+972-3-6240871
tsipih@netvision.net.il

 BioLineRx Ltd.CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION(UNAUDITED)Convenience
translation into
USDDecember 31,September 30,September 30,201220132013NIS in thousandsIn thousandsAssetsCURRENT ASSETSCash and cash equivalents

68,339

42,961

12,146Short-term bank deposits

11,459

28,688

8,111Prepaid expenses

804

809

229Other receivables

2,254

875

247Total current assets

82,856

73,333

20,733,NON-CURRENT ASSETSRestricted deposits

3,513

1,933

547Long-term prepaid expenses

204

144

41Property and equipment, net

3,172

2,681

758Intangible assets, net

1,063

911

257Total non-current assets

7,952

5,669

1,603Total assets90,808

79,002

22,336Liabilities and equityCURRENT LIABILITIESCurrent maturities of long-term bank loan

137

-

-Accounts payable and accruals:Trade

12,283

12,564

3,552OCS

6,148

-

-Other

5,443

2,896

819Total current
'/>"/>

SOURCE BioLineRx Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
2. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
3. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
4. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
5. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
6. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
7. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
8. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
9. BioLineRx to Present at 15th International Celiac Disease Symposium
10. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
11. BioLineRx Appoints B. J. Bormann to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014  - ... Today Lincor announced general availability of MediaLINC ... delivers a range of education, entertainment and clinical content ... (Logo: http://photos.prnewswire.com/prnh/20140822/702945) , " Lincor ... care patient engagement to bedside smart devices, " comments ...
(Date:8/22/2014)... 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced ... of common stock and warrants at a price of ... prior to deducting underwriting discounts and commissions and offering ... are immediately separable and will be issued separately.  The ... on The NASDAQ Stock Market under the ticker symbol ...
(Date:8/21/2014)... Nektar Therapeutics (NASDAQ: NKTR ... results from its Phase 3 pivotal clinical trial ... factor VIII (rFVIII) treatment for hemophilia A based ... primary endpoint in reducing annualized bleed rates (ABR) ... arm. Top-line results from the prospective, ...
Breaking Medicine Technology:Lincor Unveils Next Generation TV-based Patient Engagement Solution 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5
... VHGI Holdings, Inc. (OTCQX: VHGI) and VHGI Gold, LLC, ... increased its holdings in  their Sun Gold Project located between ... making the claim site over 500 acres from the previous ... plan and the initial evaluation of the area with our ...
... March 30, 2011 ThermoGenesis Corp. (Nasdaq: ... services that process and store adult stem cells, said ... regenerative medicine company, will be utilizing its AXP® AutoXpress™ ... stem cells from cord blood in its two stem ...
Cached Medicine Technology:VHGI Holdings, Inc. Announces Expansion of Sun Gold Project 2Major China Regenerative Medicine Company Adopts ThermoGenesis Cord Blood Stem Cell Processing And Storage Technologies 2Major China Regenerative Medicine Company Adopts ThermoGenesis Cord Blood Stem Cell Processing And Storage Technologies 3Major China Regenerative Medicine Company Adopts ThermoGenesis Cord Blood Stem Cell Processing And Storage Technologies 4
(Date:8/22/2014)... Va. (PRWEB) August 22, 2014 On ... Center for Medical and Health Sciences , hosting a ... area’s top influencers in government and public welfare. , ... College of Osteopathic Medicine (LUCOM) joined Liberty staff, ... and the launch of the new medical school. Classes ...
(Date:8/22/2014)... City, UT (PRWEB) August 22, 2014 ... published a new guide on Account-Based Health Plans. , ... plans (ABHPs) as a strategy to lower the cost ... different types of medical spending accounts, however, can be ... comparison chart to learn the four main types of ...
(Date:8/22/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) has ... highly recommended FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ) and BlueHost ... 10 Best SEO Hosting states, “It is hard ... Actually, these companies have outperformed their competitors on ... People can get the best web hosting at ...
(Date:8/22/2014)... 2014 Recently, UWDress.com, a leading online supplier ... a new range of empire bridesmaid dresses to ... launched a summer promotion for these high quality items. All ... 25 to 75 percent off. , The company’s new ... offers efficient assistance on its website. It is true that ...
(Date:8/22/2014)... 22, 2014 Buying a policy for different ... is unsure about available coverage types by insurers in the ... insurance policy pricing to the public using its sortable tool ... tool is free and is expected to promote the discounts ... public throughout the U.S. The system is designed to help ...
Breaking Medicine News(10 mins):Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 3Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 4Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2Health News:Discounted Empire Bridesmaid Dresses Online At UWDress.com 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2
... patients, ill afford it, and simply discontinue the treatment. ... breast cancer patients, nearly half of // total breast ... charges. Out of the 164 women surveyed in England ... discontinue the treatment due to the cost factor. ...
... Foundation, even as the UK seeks to win the football World Cup. ... how much importance men give to the game. Evaluations will be made ... jobs just for the pleasure of watching the game, and as to ... participate in the game itself. ,The Health Charity will ...
... benefits with your doctor does not seems to benefit the ... University of California, San Francisco found in a study ... shared the decision with their doctor. ,The researchers ... did not benefit the patient in deciding the symptoms and ...
... been warned by the Manitoba Ombudsman that they should ... while receiving emergency// contraception. A woman had already complained ... she was buying the Levonorgestrel, also called the drug ... the woman’s sexual relations. Such medicines do not require ...
... suit has been filed against Apple Computer in a California ... been called defective, and capable of damaging the hearing of ... of Louisiana. // ,Patterson's lawsuit contends that ... out sound of between 115 and 130 decibels, about the ...
... Two little girls in the Indian State of Orissa are facing ... Kanaklata and Rashmita have only their uncle to count on for ... Their father Sourendra worked in Mumbai as a laborer for nearly ... Sourendra's elder brother Gouranga Naik said. Sourendra who was suffering from ...
Cached Medicine News:
Biopsy forceps...
Incontinence Pessaries...
Indications: for young women who experience stress urinary incontinence when excercising vigorously; i.e., aerobics, tennis, jogging....
... pessary is designed for third ... well as a cystocele and ... available both with and without ... silicone tie to aid in ...
Medicine Products: